RxDoctor Payments Data

Jay Simonson

Cardiovascular Disease · St Louis Park, MNNPI 1083691513

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $286,580 of the $309,013 with a category attached, or 92.7%. Abbott accounts for 79.0% of it on its own, with 7 other manufacturers making up the rest. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$309,013in general payments, 2019–2025

Across 244 payments — averaging $1266.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$244K
  • Integer Holdings Corporation$40K
  • Medtronic$12K
  • Occlutech US LLC$9K
  • Boston Scientific$2K
  • Medical Device Business Services, Inc.$824
  • plus $802 from 2 others
$84,221in research payments, 2019–2025

Across 35 payments — averaging $2406.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$84K

What the payments were for

  • Consulting fees$286,58093%
  • Speaking & faculty fees$12,1504%
  • Grants$8,8753%
  • Travel & lodging$9310%
  • Food & beverage$4770%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott202$244,019
Integer Holdings Corporation16$40,050
Medtronic(2 entities)15$12,443
Occlutech US LLC1$8,875
Boston Scientific1$2,000
Medical Device Business Services, Inc.3$824
W. L. Gore & Associates, Inc.1$580
Biosense Webster, Inc.5$222

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$309,013 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota

Medicare billing

Part B allowed, 2024
$178,204
Medicare patients
1,195
Services billed
2,444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban256$299,462
XareltoRivaroxaban22$34,418
Flecainide Acetate157$5,374
Metoprolol Succinate191$3,704
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$763
Amiodarone Hcl26$614
Omeprazole53$500
SotalolSotalol Hcl17$414
Losartan Potassium28$347
Amlodipine Besylate12$196
Atorvastatin Calcium13$84
Metoprolol Tartrate18$63

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in St Louis Park

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →